|
|
||||||||
1 Departament de Farmacologia, Facultat de Medicina i Odontologia, Universitat de València, 46010 València, Spain; 2 Faculté de Médecine Paris-Ouest, Unité de Formation et de Recherche Biomédicale des Saint Pères, and Centre Hospitalier de Versailles, 78157 Le Chesnay, France; and 3 Shanghai Second Medical University, 200025 Shanghai, China
The
muscarinic functional antagonism of isoproterenol relaxation and the
contribution of muscarinic M2 receptors were examined in
human isolated bronchus. In intact tissues, acetylcholine (ACh) precontraction decreased isoproterenol potency and maximal relaxation (
log EC50 shift =
1.49 ± 0.16 and
Emax inhibition for 100 µM ACh = 30%) more than the
same levels of histamine contraction. The M2
receptor-selective antagonist methoctramine (1 µM) reduced this
antagonism in ACh- but not histamine-contracted tissues. Similar
results were obtained for forskolin-induced relaxation. After selective
inactivation of M3 receptors with
4-diphenylacetoxy-N-(2-chloroethyl)piperadine hydrochloric
acid (30 nM), demonstrated by abolition of contractile and inositol
phosphate responses to ACh, muscarinic recontractile responses were
obtained in U-46619-precontracted tissues fully relaxed with
isoproterenol. Methoctramine antagonized recontraction, with
pKB (6.9) higher than in intact tissues (5.4), suggesting participation of M2 receptors. In
M3-inactivated tissues, methoctramine augmented the
isoproterenol relaxant potency in U-46619-contracted bronchus and
reversed the ACh-induced inhibition of isoproterenol cAMP accumulation.
These results indicate that M2 receptors cause indirect
contraction of human bronchus by reversing sympathetically mediated
relaxation and contribute to cholinergic functional antagonism.
airway smooth muscle; muscarinic receptors; methoctramine; 4-diphenylacetoxy-N-(2-chloroethyl)piperadine hydrochloric acid
This article has been cited by other articles:
![]() |
E. Naline, A. Trifilieff, R. A. Fairhurst, C. Advenier, and M. Molimard Effect of indacaterol, a novel long-acting {beta}2-agonist, on isolated human bronchi Eur. Respir. J., March 1, 2007; 29(3): 575 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Johnson Corticosteroids: Potential {beta}2-Agonist and Anticholinergic Interactions in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 320 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fayon, E. Dumas De La Roque, P. Berger, H. Begueret, O. Ousova, M. Molimard, and R. Marthan Increased relaxation of immature airways to {beta}2-adrenoceptor agonists is related to attenuated expression of postjunctional smooth muscle muscarinic M2 receptors J Appl Physiol, April 1, 2005; 98(4): 1526 - 1533. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |